Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects
Authors
Keywords
Psoriasis, Adalimumab, Allergic Contact Dermatitis, Plaque Psoriasis, Ustekinumab
Journal
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume 17, Issue 4, Pages 349-358
Publisher
Springer Nature
Online
2016-04-25
DOI
10.1007/s40257-016-0191-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
- (2016) Carina Götestam Skorpen et al. ANNALS OF THE RHEUMATIC DISEASES
- Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
- (2015) Melinda Gooderham et al. BIODRUGS
- Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)
- (2015) C. Paul et al. BRITISH JOURNAL OF DERMATOLOGY
- Broad-band UVB versus paint PUVA for palmoplantar psoriasis treatment
- (2015) Alina Lozinski et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14 , but Not with Loss-of-Function Mutations in IL36RN in European Patients
- (2015) Rotraut Mössner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
- (2015) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Compliance with pregnancy prevention plan recommendations in 8672 French women of childbearing potential exposed to acitretin
- (2015) Fanny Raguideau et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis
- (2014) Jina Chung et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion
- (2014) M. Sevrain et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Resistant Palmoplantar Lesions in Patients of Psoriasis: Evaluation of the Causes and Comparison of the Frequency of Delayed-Type Hypersensitivity in Patients without Palm and Sole Lesions
- (2014) Nawaf Al-Mutairi et al. MEDICAL PRINCIPLES AND PRACTICE
- Clinical and epidemiological comparison of patients affected by palmoplantar plaque psoriasis and palmoplantar pustulosis: a case series study
- (2013) A.M.G. Brunasso et al. BRITISH JOURNAL OF DERMATOLOGY
- Pharmacogenetics of psoriasis:HLA-Cw6but notLCE3B/3Cdeletion norTNFAIP3polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab
- (2013) M. Talamonti et al. BRITISH JOURNAL OF DERMATOLOGY
- Tonsillectomy as a treatment for psoriasis: A review
- (2013) Wiggin Wu et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial
- (2013) R. Bissonnette et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- UVA-1 Laser in the Treatment of Palmoplantar Pustular Psoriasis
- (2013) Steven Paul Nisticò et al. PHOTOMEDICINE AND LASER SURGERY
- Alitretinoin abrogates innate inflammation in palmoplantar pustular psoriasis
- (2012) N. Irla et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis
- (2012) C. Morales-Múnera et al. BRITISH JOURNAL OF DERMATOLOGY
- Infliximab-Induced Palmoplantar Psoriasis in a Patient With Ankylosing Spondylitis
- (2012) Erhan Çapkin et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis
- (2012) Shiu-Chung Au et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study
- (2012) A.B. Janagond et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Management of palmoplantar pustulosis: do we need to change?
- (2011) U. Mrowietz et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy of excimer light therapy (308 nm) for palmoplantar pustulosis with the induction of circulating regulatory T cells
- (2011) Takuya Furuhashi et al. EXPERIMENTAL DERMATOLOGY
- Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum
- (2011) Masamoto Murakami et al. EXPERIMENTAL DERMATOLOGY
- Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study
- (2011) R. Bissonnette et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy
- (2011) Roberto Pérez-Alvarez et al. MEDICINE
- Comparative therapeutic evaluation of different topicals and narrow band ultraviolet B therapy combined with systemic methotrexate in the treatment of palmoplantar psoriasis
- (2011) SunilK Gupta et al. INDIAN JOURNAL OF DERMATOLOGY
- Increased IL-23 Expression in Palmoplantar Psoriasis and Hyperkeratotic Hand Dermatitis
- (2010) Joseph V. Lillis et al. ARCHIVES OF DERMATOLOGY
- Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet
- (2010) Craig Leonardi et al. ARCHIVES OF DERMATOLOGY
- Ustekinumab in the treatment of palmoplantar pustulosis
- (2010) S. Gerdes et al. BRITISH JOURNAL OF DERMATOLOGY
- Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis
- (2010) E. Hagforsen et al. BRITISH JOURNAL OF DERMATOLOGY
- Onset of palmoplantar pustular psoriasis while on adalimumab for psoriatic arthritis: A ‘class effect’ of TNF-α antagonists or simply an anti-psoriatic treatment adverse reaction?
- (2010) Efstathios Rallis et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Acrosyringium Is the Main Site of the Vesicle/Pustule Formation in Palmoplantar Pustulosis
- (2010) Masamoto Murakami et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pharmacogenetics of psoriasis
- (2010) Darren D O’Rielly et al. PHARMACOGENOMICS
- Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata
- (2009) Uwe Wollina et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Palmoplantar psoriasis: A phenotypical and clinical review with introduction of a new quality-of-life assessment tool
- (2009) Elizabeth Farley et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efalizumab for severe palmo-plantar psoriasis: an open-label pilot trial in five patients
- (2009) AMG Brunasso et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Extra-palmoplantar lesions associated with palmoplantar pustulosis
- (2009) T Yamamoto JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients
- (2009) E Adışen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Palmoplantar pustulosis should not be considered as a variant of psoriasis
- (2007) A Ammoury et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now